Expanded Access of Occlutech's Atrial Flow Regulator

Available (expanded access)

In brief

Occlutech AFR use allowed per FDA's Expanded Access program.

Key facts

Study ID

NCT07421557

Run by

Occlutech International AB

Last updated by the study team

2026-02-19

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Individual Sites Across the U.S. — Maple Grove, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.